Wellington Management Group LLP Zymeworks Inc. Transaction History

Wellington Management Group LLP

  • $548 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.82 - $7.7 $5.67 Million - $9.05 Million
-1,175,788 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$6.0 - $16.98 $10.1 Million - $28.5 Million
-1,681,198 Reduced 58.85%
1,175,788 $7.7 Million
Q4 2021

Feb 11, 2022
BUY
$15.19 - $29.33 $34.3 Million - $66.2 Million
2,257,851 Added 376.85%
2,856,986 $46.8 Million
Q3 2021

Nov 15, 2021
BUY
$27.35 - $37.28 $16.4 Million - $22.3 Million
599,135 New
599,135 $17.4 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $766M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email